Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Hitomi Sakai"'
Autor:
Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, Koji Matsumoto, Akihiko Shimomura, Mihoko Doi, Yasuo Miyoshi, Masato Takahashi, Yasuaki Sagara, Shinya Tokunaga, Tsutomu Iwasa, Naoki Niikura, Kenichi Yoshimura, Toshimi Takano, Junji Tsurutani
Publikováno v:
Breast, Vol 71, Iss , Pp 22-28 (2023)
Background: Abemaciclib-induced diarrhea (AID) impairs quality of life (QOL) and treatment adherence in patients with breast cancer. Supportive treatment with loperamide is associated with constipation. We hypothesized that probiotics and trimebutine
Externí odkaz:
https://doaj.org/article/3544c75755a544df9159617d47de13e3
Autor:
Hiroji Iwata, Kenichi Yoshimura, Norikazu Masuda, Kenjiro Aogi, Yuko Tanabe, Koji Matsumoto, Masato Takahashi, Hitomi Sakai, Junji Tsurutani, Chiyo K Imamura, Tsutomu Iwasa, Toshimi Takano, Kiyoshi Yoshimura, Jun Masuda, Manabu Futamura, Mari Hosonaga, Toru Mukohara, Sakiko Miura, Toshiko Yamochi, Hidetaka Kawabata, Hiroyuki Yasojima, Nobumoto Tomioka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 9 (2023)
Background Hormone receptor (HR)-positive breast cancer is a disease for which no immune checkpoint inhibitors have shown promise as effective therapies. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors synergistically increased the effectiveness
Externí odkaz:
https://doaj.org/article/48eaa440eb16414586e7459b2d147b7c
Autor:
Shigeto Maeda, Yasutaka Chiba, Koji Matsumoto, Hitomi Sakai, Junji Tsurutani, Yukinori Ozaki, Hiroshi Ishiguro, Kazuki Nozawa, Kenichi Watanabe, Takamichi Yokoe, Chiyo K Imamura, Tsutomu Iwasa, Daisuke Takiguchi, Toshimi Takano
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) has led to a change in the clinical management of breast cancer. Nausea and vomiting are the most common adverse events of T-DXd, which cannot be completely alleviated by standar
Externí odkaz:
https://doaj.org/article/5396e6da4ac945788e161e23d013d88e
Autor:
Hitomi Sakai, Hisato Kawakami, Takeshi Teramura, Yuta Onodera, Elizabeth Somers, Keiji Furuuchi, Toshimitsu Uenaka, Ryoji Kato, Kazuhiko Nakagawa
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Abstract Background The main function of folate receptor α (FOLRα) has been considered to mediate intracellular folate uptake and induce tumor cell proliferation. Given the broad spectrum of expression among malignant tumors, including gastric canc
Externí odkaz:
https://doaj.org/article/123305652e1b46c1a6de16796002c111
Publikováno v:
兵庫県立大学環境人間学部研究報告 = Research reports. 25:33-40
Autor:
Yoshio Itani, Hitomi Sakai, Tetsutaro Hamano, Mikiko Asai‐Sato, Masayuki Futagami, Masaki Fujimura, Yoichi Aoki, Nao Suzuki, Yoshio Yoshida, Takayuki Enomoto
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 49:1400-1411
Autor:
Meiko Nishimura, Takahiro Kogawa, Yuko Akaishi, Misato Ogata, Jun Masuda, Mitsuo Terada, Hitomi Sakai, Kazuki Nozawa, Sasagu Kurozumi, Takamichi Yokoe, Yukinori Ozaki Ozaki, Shu Yazaki, Mai Onishi, Tsutomu Iwasa, Takuma Onoe, Yuta Okumura, Sayaka Nakayama, Kanako Hagio, Yuko Takahashi, Hirokazu Tanino, Junji Tsurutani, Koji Matsumoto, Mototsugu Shimokawa, Toshimi Takano
Publikováno v:
Cancer Research. 82:OT2-19
Background: Abemaciclib is a drug approved for ER-positive and HER2-negative metastatic or recurrent breast cancer and those treatable in an early setting. Some patients with ER-positive and HER2-negative breast cancer pretreated with abemaciclib and
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masaaki Miyazawa, Kenji Hirotani, Michiko Yamato, Hiroyasu Kaneda, Yoshikazu Hasegawa, Keita Kudo, Takafumi Okabe, Yasutaka Chiba, Kazuko Sakai, Osamu Maenishi, Sigeki Kato, Masayuki Takeda, Hidetoshi Hayashi, Kaoru Tanaka, Takayuki Takahama, Naoki Takegawa, Ryoji Kato, Hitomi Sakai, Shiki Takamura, Koji Haratani, Kimio Yonesaka
Cox proportional hazard model for PFS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505dd07e89ca0903d27a29cfc2bd0676
https://doi.org/10.1158/1078-0432.22464515.v1
https://doi.org/10.1158/1078-0432.22464515.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masaaki Miyazawa, Kenji Hirotani, Michiko Yamato, Hiroyasu Kaneda, Yoshikazu Hasegawa, Keita Kudo, Takafumi Okabe, Yasutaka Chiba, Kazuko Sakai, Osamu Maenishi, Sigeki Kato, Masayuki Takeda, Hidetoshi Hayashi, Kaoru Tanaka, Takayuki Takahama, Naoki Takegawa, Ryoji Kato, Hitomi Sakai, Shiki Takamura, Koji Haratani, Kimio Yonesaka
Effect of using a combination of targeting B7-H3 and PD-L1 on body weight in the murine tumor model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d23b233794e7c93aca35e20ccea76fe
https://doi.org/10.1158/1078-0432.22464524
https://doi.org/10.1158/1078-0432.22464524
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Kazuko Sakai, Hidetoshi Hayashi, Hisato Kawakami, Junko Tanizaki, Koji Haratani, Hitomi Sakai, Ryoji Kato, Toshiyuki Takehara, Takeshi Teramura, Kimio Yonesaka, Shinichiro Suzuki
Purpose:Treatment with KRASG12C inhibitors such as sotorasib can produce substantial regression of tumors in some patients with non–small cell lung cancer (NSCLC). These patients require alternative treatment after acquiring resistance to the inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515508c588c2e1caeb4109c863e2de8b
https://doi.org/10.1158/1078-0432.c.6530453.v1
https://doi.org/10.1158/1078-0432.c.6530453.v1